AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICLR
  4. [6-K] Icon Plc Current Report (Foreign Issuer)

[6-K] Icon Plc Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:


 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934


For the month of July 2025


333-08704
(Commission file number)


ICON plc
(Translation of registrant's name into English)


South County Business Park, Leopardstown, Dublin 18, D18 X5R3, Ireland
(Address of principal executive offices)




Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F __X___
Form 40-F ______
 


EXHIBIT LIST
 
ExhibitDescription
  
99.1
ICON plc Press Release issued July 23, 2025 - ICON Reports Second Quarter 2025 Results


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
  ICON plc
   
  /s/ Nigel Clerkin
Date: July 23, 2025 
Nigel Clerkin
Chief Financial Officer

Source:

FAQ

What information is available?

This document appears to contain limited substantive content.
Stock ICLR logo
ICON PLC

NASDAQ:ICLR

ICLR Rankings

#947 Ranked by Market Cap
N/A Ranked by Dividends

ICLR Latest News

Jul 23, 2025
ICON Announces Results of Annual General Meeting
Jul 23, 2025
ICON Reports Second Quarter 2025 Results
Jul 16, 2025
ICON鈥檚 Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
Jul 7, 2025
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
Jun 23, 2025
ICON plc Schedules Second Quarter 2025 Earnings Conference Call

ICLR Latest SEC Filings

Jul 24, 2025
[6-K] Icon Plc Current Report (Foreign Issuer)
Jul 23, 2025
[6-K] Icon Plc Current Report (Foreign Issuer)
Jul 3, 2025
[SCHEDULE 13G/A] Icon Plc SEC Filing
Jun 23, 2025
[6-K] Icon Plc Current Report (Foreign Issuer)
Jun 18, 2025
[6-K] Icon Plc Current Report (Foreign Issuer)

ICLR Stock Data

12.84B
78.98M
0.61%
98.56%
2.09%
Diagnostics & Research
Healthcare
Ireland
Dublin